FMT Tied to Health Improvements Beyond Infection Clearance – MedPage Today

Apart from infection clearance, fecal microbiota transplant (FMT) was associated with a range of positive health outcomes in severely compromised patients with multidrug-resistant infections, preliminary results from a small U.K. pilot study suggested. The open-label study of 20 patients infected during repeated hospitalizations was presented in an online press program organized by Digestive Disease Week (DDW), which was to have started this weekend but was cancelled because of the COVID-19 pandemic.

Read more
Induced Pluripotent Stem Cells Market to Witness CAGR 8.7% Growth in Revenue During the Period 2026 – Cole of Duty

The healthcare industry has been focusing on excessive research and development in the last couple of decades to ensure that the need to address issues related to the availability of drugs and treatments for certain chronic diseases is effectively met. Healthcare researchers and scientists at the Li Ka Shing Faculty of Medicine of the Hong Kong University have successfully demonstrated the utilization of human induced pluripotent stem cells or hiPSCs from the skin cells of the patient for testing therapeutic drugs.

Read more
Biocardia Announces FDA-Recommended Modifications to Primary Endpoint for Cardiamp Cell Therapy Heart Failure Trial to Support Marketing Approval -…

SAN CARLOS, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- BioCardia, Inc.[Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported that it has accepted and implemented FDA-recommended modifications to the primary endpoint for the CardiAMP Cell Therapy Heart Failure Trial and associated statistical analysis plan. The Agency proposed these modifications to support the potential for marketing approval for the therapy based on the currently enrolling pivotal trial. The primary endpoint going forward will be an outcomes composite score based on a three-tiered Finkelstein-Schoenfeld (FS) hierarchical analysis, an established outcomes design that has been used in other leading heart failure programs.

Read more
Coronavirus (COVID-19) Business Impact Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size of Dynamics, Products, Application Forecast…

Study on the Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market The report on the global Platelet Rich Plasma and Stem Cell Alopecia Treatment market reveals that the Platelet Rich Plasma and Stem Cell Alopecia Treatment market is anticipated to grow at a CAGR of ~XX% during the forecast period (2019-2029). The report provides a thorough assessment of the impact of the COVID-19 pandemic on the current and future prospects of the Platelet Rich Plasma and Stem Cell Alopecia Treatment market across various geographies

Read more
Lack of investment is the biggest challenge in stem cell research – Express Healthcare

India with its huge population can become an ideal place for medical research in stem cell, but due to lack of awareness and investment, its progress is slowing down. Vipul Jain, CEO, Advancells talks about the companys vision for stem cell research and progress in India, to Usha Sharma Give us a brief about your companys inception? I have been a part of healthcare marketing for over 12 years now and somewhere in 2009-10, a few patients started talking about stem cell therapies if I could help them find a centre, where they could opt for these therapies.

Read more
Stem Cell Banking Industry Market Booming Demand Leading To Exponential CAGR Growth By 2026 | UpMarketResearch Cole Reports – Cole of Duty

The Global Stem Cell Banking Industry Market analysis report published on Upmarketresearch.com is a detailed study of market size, share and dynamics covered in XX pages and is an illustrative sample demonstrating market trends. This is a latest report, covering the current COVID-19 impact on the market

Read more